XARMAPSII
LIVE

Serial Number

98196234

Owner

REGENXBIO INC.

Attorney

William R. Samuels

Filing Date

Sep 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

XARMAPSII Trademark

Serial Number: 98196234

XARMAPSII is a trademark filed by REGENXBIO INC. on September 25, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

REGENXBIO INC. (45 trademarks)

9804 Medical Center Drive
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

September 25, 2023

Registration Date

Not Registered

Published for Opposition

November 12, 2024

Goods & Services

Biological preparations for medical use in the treatment of genetic diseases and disorders, and central nervous system (CNS) disorders, namely, neurodegenerative disorders; pharmaceutical preparations, namely, recombinant adeno-associated viral (rAAV) vectors for use in gene therapy; Pharmaceutical preparations for the treatment of genetic diseases and disorders and central nervous system (CNS) disorders, namely, neurodegenerative disorders; Pharmaceutical preparations for use in gene therapy; Clinical medical reagents for use in gene therapy; Pharmaceutical preparations for the treatment of genetic disorders and neurodegenerative disorders; Therapeutic pharmaceutical compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; Pharmaceutical preparations containing adeno-associated viral (AAV) vectors and nucleic acids for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, lysosomal storage disorders; gene therapy preparation for medical use containing genetic materials for sustained protein expression, namely, lysosomal enzyme expression

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 22, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 22, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 20, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 20, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 20, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 24, 2024 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 12, 2024 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 3, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 3, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 3, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 3, 2024 CNEA
ATTORNEY REVIEW COMPLETED
Jul 26, 2024 ATRV
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 24, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 24, 2024 PARI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 10, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 10, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 17, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 10, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2023 NWOS
NEW APPLICATION ENTERED
Sep 28, 2023 NWAP